STOCK TITAN

Restricted stock vesting notice at PRCT (NASDAQ: PRCT) with prior insider sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

PRCT submitted a Form 144 notice reporting a proposed sale of Common stock tied to a restricted stock vesting event dated 03/16/2026. The filing also records a prior sale by Kevin Waters of 6,721 shares on 03/06/2026 for $159,300.47.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notifies the market of an intended sale tied to vesting; prior sale details are disclosed.

The notice lists a proposed sale of Common stock associated with a restricted stock vesting on 03/16/2026. Filings of this type serve as a regulatory notice under resale rules for insiders and affiliates.

Cash‑flow treatment and the exact number of shares proposed for resale are not specified in the excerpt; the filing does list a prior sale by Kevin Waters of 6,721 shares on 03/06/2026 for $159,300.47. Subsequent disclosures or broker statements would show actual sale timing and executed amounts.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does PRCT's Form 144 filing mean?

It is a regulatory notice of a proposed sale of PRCT common stock tied to restricted stock vesting on 03/16/2026. Such filings inform the market when insiders or affiliates intend to resell securities under resale rules; execution details are reported separately when sales occur.

Who is the individual associated with recent sales in the PRCT filing?

The filing identifies Kevin Waters as having sold 6,721 shares on 03/06/2026 for $159,300.47. This prior sale is disclosed in the Form 144's "Securities Sold During The Past 3 Months" section.

Is the proposed sale tied to compensation or vesting for PRCT?

Yes; the excerpt states the securities to be sold relate to Restricted Stock Vesting with an event date of 03/16/2026. The filing links the proposed resale to issuer compensation vesting rather than an open‑market purchase.

Does the Form 144 specify how many shares are proposed for sale?

The provided excerpt does not state a clear proposed sale quantity for the vesting event. It does, however, list a prior executed sale of 6,721 shares on 03/06/2026 for $159,300.47.
Procept Biorobotics Corp

NASDAQ:PRCT

View PRCT Stock Overview

PRCT Rankings

PRCT Latest News

PRCT Latest SEC Filings

PRCT Stock Data

1.58B
54.72M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SAN JOSE